Raltegravir F-18
N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
Molecular Identity
Raltegravir F-18
N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide
PubChem CID: 54741842
2D Structure
Properties
C20H21FN6O5
Molecular Formula
443.40
Molecular Weight
g/mol
443.1583
Exact Mass
Da
1.1
XLogP
Drug-like (Lipinski: < 5)
150
TPSA
May have limited oral absorption
3
H-Bond Donors
9
H-Bond Acceptors
836
Complexity
SMILES
Canonical SMILES
SMILES: CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)FIsomeric SMILES
SMILES: CC1=NN=C(O1)C(=O)NC(C)(C)C2=NC(=C(C(=O)N2C)O)C(=O)NCC3=CC=C(C=C3)[18F]Synonyms(7)
18F-RaltegravirRaltegravir F-185G8B507W3FUNII-5G8B507W3F1236352-56-94-Pyrimidinecarboxamide, N-((4-(fluoro-18F)phenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-RefChem:202836
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Raltegravir F-18
Loading drug network...